Prescription drug · BLA
NovoLog Mix 70/30 (Insulin aspart) NDC 70518-2119
Insulin aspart 100 [iU]/mL · Injection, Suspension · Subcutaneous · REMEDYREPACK INC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70518-2119-0 | 7051821190070518211900 | 5 SYRINGE, PLASTIC in 1 CARTON (70518-2119-0) / 3 mL in 1 SYRINGE, PLASTICMarketed from May 28, 2019 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- NovoLog Mix 70/30
- Generic name (nonproprietary)
- insulin aspart
- Active ingredients
- Insulin aspart — 100 [iU]/mL
- Dosage form
- Injection, Suspension
- Route
- Subcutaneous
- Labeler
- REMEDYREPACK INC.NDC labeler code 70518
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 021172
- Marketing start
- Listing expires
- Other FDA classes
- Insulin (Chemical structure)
- Identifiers
- Product ID 70518-2119_521a565a-0a44-0a60-e063-6394a90abf13SPL ID 521a565a-0a44-0a60-e063-6394a90abf13SPL set ID 66da64f7-ca50-47d2-95fa-de37005eef85RxCUI 847191, 977840UNII D933668QVX
- Pharmacologic class
- Insulin Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N470518211900followed by a unit qualifier and the quantityPackage 70518-2119-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
NOVOLOG MIX 70/30 is a mixture of insulin aspart protamine and insulin aspart indicated to improve glycemic control in adult patients with diabetes mellitus. Limitations of Use: NOVOLOG MIX 70/30 is not recommended for the treatment of diabetic ketoacidosis. The proportions of rapid-acting and long-acting insulins in NOVOLOG MIX 70/30 are fixed and do not allow for basal versus prandial dose adjustments. NOVOLOG MIX 70/30 is a mixture of insulin aspart protamine, an intermediate-acting human insulin analog, and insulin aspart, a rapid-acting human insulin analog, indicated to improve glycemic control in adult patients with diabetes mellitus. Limitations of Use: Not recommended for the treatm…
Excerpt only. Read the full label for complete information.
About NDC 70518-2119
- What is NDC 70518-2119?
- 70518-2119 is the product NDC for NovoLog Mix 70/30 (insulin aspart), Insulin aspart 100 [iU]/mL injection, suspension, listed with the FDA by REMEDYREPACK INC.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- NovoLog Mix 70/30 (Insulin aspart).
- What is the active ingredient?
- Insulin aspart.
- Who is the labeler?
- REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for NovoLog Mix 70/30?
- 5 other product NDCs are listed under this name. See all NovoLog Mix 70/30 NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other NovoLog Mix 70/30 products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-2201 | 00169-2201-25 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-3696 | 00169-3696-19 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | A-S Medication Solutions | 50090-2272 | 50090-2272-00 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-2200 | 00169-2200-11 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-3685 | 00169-3685-12 |
Other NDCs under BLA 021172
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| .Insulin Aspart Protamine and Insulin Aspartinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | A-S Medication Solutions | 50090-4959 |
| Insulin Aspart Protamine and Insulin Aspart Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | REMEDYREPACK INC. | 70518-3236 |
| Insulin Aspart Protamine and Insulin Aspart Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharma, Inc. | 73070-200 |
| Insulin Aspart Protamine and Insulin Aspart Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharma, Inc. | 73070-203 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-2200 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-2201 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-3685 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-3696 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | A-S Medication Solutions | 50090-2272 |